Education
About Us
Working with TipRanks
Follow Us
AxoGen (AXGN)
NASDAQ:AXGN
Earnings Data
Report Date
Mar 03, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.06Last Year’s EPS
0.07Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and operational performance across all target markets, driven by increased adoption and positive gross margin trends. However, some challenges were noted in reaching high potential account goals and the extended timeline for BLA approval. Despite these challenges, the overall sentiment is positive, given the robust financial performance and strategic progress.Company Guidance
Significant Revenue Growth
Q3 sales increased to $60.1 million, growing 23.5% compared to the same period last year. The growth was driven by expanding adoption of nerve care across all target markets.
Gross Margin Improvement
Gross margin increased to 76.6%, up from 74.9% in the same period last year and up from 74.2% in the second quarter of 2025, driven by lower inventory write-offs and reduced shipping costs.
Positive Adjusted EBITDA
Adjusted EBITDA for the quarter was $9.2 million, with a margin improvement to 15.4% from 13.3% in the same period last year, driven by revenue growth and increased operating leverage.
Surgeon Training and Adoption
AxoGen trained 97 surgeons in Extremities year-to-date and 57 in OMF and head and neck, exceeding targets, and saw a 20% increase in surgeons performing breast resensation procedures.
Increased Coverage and Reimbursement
Noncoverage policies removed within Blue Cross Blue Shield network and Medicare Advantage, with an estimated 1.1 million newly covered lives in Q3 and 18.1 million YTD.
AXGN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AXGN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 29, 2025 | $18.08 | $22.25 | +23.06% |
Aug 05, 2025 | $12.55 | $13.72 | +9.32% |
May 08, 2025 | $16.39 | $12.59 | -23.18% |
Feb 25, 2025 | $18.01 | $20.11 | +11.66% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AxoGen (AXGN) report earnings?
AxoGen (AXGN) is schdueled to report earning on Mar 03, 2026, After Close (Confirmed).
What is AxoGen (AXGN) earnings time?
AxoGen (AXGN) earnings time is at Mar 03, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AXGN EPS forecast?
AXGN EPS forecast for the fiscal quarter 2025 (Q4) is 0.06.